EGFR and neoplasm: Surprisingly, however, in four of the 25 adjacent non-tumour tissues samples, the assay also identified a different somatic mutation at very low levels, including two exon 20 insertion variants, one exon 19 deletion variant in EGFR and one R248W mutation in TP53 that were not detected in the original matching tumour sample.